ArticleMedical oncology (Northwood, London, England)2022

ERBB2 S310F mutation independently activates PI3K/AKT and MAPK pathways through homodimers to contribute gallbladder carcinoma growth.

Kun Fan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.